₹ 491.85
9.60 (1.99%)
B
Bafna Pharmaceuticals
₹ 491.85
Bafna Pharmaceuticals Fundamentals
Company Valuation
Market Cap (₹ Cr.)
1,164
PE Ratio
147.30
PB Ratio
11.92
Dividend Yield
-
ROE
-3.68%
ROCE
-3.30%
Book Value (₹)
40.64
Face Value (₹)
10.00
Analyse BAFNAPH with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|
| Promoters | 75.00% | 75.00% | 75.00% | 75.00% | 75.00% |
| Domestic Institutional Investors (DII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Foreign Institutional Investors (FII) | 9.34% | 9.34% | 9.34% | 9.34% | 9.34% |
| Public Investors | 12.03% | 12.13% | 12.13% | 11.97% | 11.97% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
BAFNAPH Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals & Biotechnology
Company Classification
Microcap
BSE Scrip Code
532989
NSE Scrip Name
BAFNAPH
ISIN
INE878I01022

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






